Phase II trial to evaluate efficacy and toxicity of cetuximab plus docetaxel in platinum pretreated patients with recurrent and/or metastatic head and neck cancer

Knoedler, M. and Gauler, T. C. and Matzdorff, A. and Dietz, A. and Gruenwald, V. and Arnold, D. and Hennemann, B. and Schroeder, M. and Hofele, C. and Schmittel, A. and Keilholz, U. (2008) Phase II trial to evaluate efficacy and toxicity of cetuximab plus docetaxel in platinum pretreated patients with recurrent and/or metastatic head and neck cancer. JOURNAL OF CLINICAL ONCOLOGY, 26 (15supp): 6066. ISSN 0732-183X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 14 Jan 2021 16:12
Last Modified: 14 Jan 2021 16:12
URI: https://pred.uni-regensburg.de/id/eprint/30894

Actions (login required)

View Item View Item